Form 4: Aspira Women's Health Director Stefanie Cavanaugh Acquires Restricted Stock Units

Director Stefanie Cavanaugh acquired 23,750 restricted stock units in Aspira Women's Health Inc.

Summary

• On August 22, 2024, Stefanie Cavanaugh, a director of Aspira Women's Health Inc., acquired 23,750 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Aspira Women's Health Inc.'s common stock.
• The RSUs will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025, and the date of the annual shareholders' meeting, contingent upon continued service to the Issuer.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock unit acquisition. The vesting schedule suggests a positive outlook, but it's not overtly bullish.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs indicates a multi-year commitment from the director to the company.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's stock.

Stakeholder Impact

• The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

Aspira Women's Health, Restricted Stock Units, Director, Acquisition, AWH, Form 4, Beneficial Ownership